Alteogen Enters Option and License Agreement with Novartis for Development and Commercialization of Hybrozyme™-Enabled Subcutaneous Products

Alteogen Enters Option and License Agreement with Novartis for Development and Commercialization of Hybrozyme™-Enabled Subcutaneous Products

Novartis obtains rights to develop and commercialize subcutaneous formulations for multiple products utilizing ALT-B4 Alteogen's fourth licensing agreement signed this year further accelerating the expansion of the Hybrozyme™ platform DAEJEON, South...

Simcere Zaiming Enters Exclusive License Agreement with Roche for SIM0660 Global Development

Simcere Zaiming Enters Exclusive License Agreement with Roche for SIM0660 Global Development

NANJING, China, Sept. 1, 2026 /PRNewswire/ -- Simcere Zaiming, a subsidiary of Simcere Pharmaceutical Group (2096.HK) today announced that it has entered into an exclusive global licensing agreement with Roche for the development and...

YY Group Enters New Era as YYForce, Expanding AI, Automation and Human-Robot Workforce Strategy; Nasdaq Ticker Changes to "YFOR"

YY Group Enters New Era as YYForce, Expanding AI, Automation and Human-Robot Workforce Strategy; Nasdaq Ticker Changes to "YFOR"

New name reflects evolution into automation and AI-enabled workforce management and integrated facility management (IFM) infrastructure platform Trading under new ticker symbol YFOR expected to commence September 2, 2026 SINGAPORE, Sept. 1, 2026...

DualityBio Enters a Global Collaboration and License Agreement with Genentech to Develop Next-Generation ADCs Built on DualityBio's DUPAC Novel-Payload Platform

DualityBio Enters a Global Collaboration and License Agreement with Genentech to Develop Next-Generation ADCs Built on DualityBio's DUPAC Novel-Payload Platform

Collaboration leverages DualityBio's proprietary DUPAC payload platform and early global clinical development capabilities, with Genentech assuming further clinical development and global commercialization DUPAC, one of the DualityBio's four...

Flexsys Narrows 6PPD Replacement to Two Final Molecules and Enters Cooperative Research and Development Agreement with U.S. Geological Survey for Independent Toxicity Testing

Flexsys Narrows 6PPD Replacement to Two Final Molecules and Enters Cooperative Research and Development Agreement with U.S. Geological Survey for Independent Toxicity Testing

These two steps bring a 6PPD replacement closer to market, as federal scientists will conduct extensive aquatic toxicity testing - a critical step toward final molecule selection and commercialization. AKRON, Ohio, Aug. 27, 2026 /PRNewswire/ --...

Context Labs Enters Multi-Year Agreement with Trafigura and Acquires Kinertic to Power Carbon-Informed Commodities Trading

Context Labs Enters Multi-Year Agreement with Trafigura and Acquires Kinertic to Power Carbon-Informed Commodities Trading

Industrial AI platform will connect primary emissions data to operating entities and trading desks in oil, gas and metals across Trafigura's global portfolio AMSTERDAM, Aug. 12, 2026 /PRNewswire/ -- Context Labs B.V. ("Context Labs"), the industrial...

Planet Green Enters the Fast Growing Global Lactoferrin Market, Adding Chief Scientist to Drive Innovation-Based Product Portfolio Growth

Planet Green Enters the Fast Growing Global Lactoferrin Market, Adding Chief Scientist to Drive Innovation-Based Product Portfolio Growth

Company Gains Access to Rare and Commercially Desirable High-Quality Lactoferrin for the Large and Rapidly Scaling Chinese Markets, Adding New Scientist to Drive New Product Development NEW YORK, Aug. 11, 2026 /PRNewswire/ -- Planet Green Holdings...

Debia Enters a New Era of Growth with Strategic Investment from Newland Digital Technology

Debia Enters a New Era of Growth with Strategic Investment from Newland Digital Technology

Investment by the Shenzhen-listed technology group strengthens Debia's technology capabilities and accelerates its ambition to become a leading digital payments platform across ASEAN. SINGAPORE, Aug. 11, 2026 /PRNewswire/ -- Debia Pte. Ltd....

Thrupp & Maberly: Historic British Coachbuilder Enters a New Era of Bespoke Motor Cars

Thrupp & Maberly: Historic British Coachbuilder Enters a New Era of Bespoke Motor Cars

COVENTRY, England, Aug. 7, 2026 /PRNewswire/ -- One of Britain's most historic names in coachbuilding enters a new chapter. Thrupp & Maberly, whose origins trace back to the eighteenth century, returns as a contemporary British coachbuilding...

SOPHiA GENETICS Enters Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies

SOPHiA GENETICS Enters Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies

BOSTON and ROLLE, Switzerland, Aug. 4, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH) today announced a new global collaboration to develop, validate, and deploy two companion diagnostics (CDx) supporting precision oncology therapies with...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • menu
    menu